Corvidia Therapeutics raises $26 mln in Series A funding
Corvidia Therapeutics, a biotechnology company developing cardiovascular therapies, raised $26 million in a Series A financing round co-led by Apple Tree Partners and existing backer Sofinnova Partners. In conjunction with the financing, Seth Harrison, managing partner at Apple Tree, and Adrien Lemoine of drugmaker AstraZeneca, will join Corvidia’s board.
17 February 2016•4 mins read
